Exploring the Role of Angiopoietins in Retinal Diseases

• This educational event is presented by Genentech®.
  Sumit Sharma, MD
  **This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2022 or its accredited provider.

Welcome and Announcements

Interesting Diagnoses made by OCT

• Steve Yeh, MD

Q&A

What’s New in Imaging?

• SriniVas Sadda, MD

Q&A

Diagnosis and Evaluation of GA and Precursor Lesions in AMD

• Glenn J. Jaffe, MD

Q&A

Nonperfusion in Diabetic Retinopthy

• SriniVas Sadda, MD

Q&A

Retinal Imaging: Not Always Clinically Relevant in DME

• Sophie J. Bakri, MD

Q&A

CRVO: What a Photo Can Tell You? New Understandings from Imaging Modalities and How to Optimize Patient Outcomes

• TBD

Q&A

Refreshments and Networking in the Exhibit Hall

The Impact of Twitter Use Among Academic Ophthalmologists

• Sunir J. Garg, MD, FACS

Q&A

Lifetime Fluorescence Imaging

• Rishi P. Singh, MD

Q&A

Home Monitoring to Detect Onset of CNV: Today and Tomorrow

• TBD

Q&A

Recent Challenges of Artificial Intelligence in Retinal Disease

• TBD

Q&A

Refreshments and Networking in the Exhibit Hall

Panel Discussion

• Moderator: Peter K. Kaiser, MD
  Panelists: Robert L. Avery, MD; Glenn J. Jaffe, MD; Judy E. Kim, MD; Sunir J. Garg, MD; SriniVas Sadda, MD

Addressing Anti-VEGF Durability Issues Through Novel Surgical Approaches for the Treatment of nAMD and DME

• Supported by an educational grant from Genentech, a member of the Roche Group.
  Activity Chair: Carl D. Regillo, MD, FACS
  Faculty: Margaret A. Chang, MD, MS; Dilsher S. Dhoot, MD

Practical Training in Equipment, Technology, and Insurance

• **This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2022 or its accredited provider.

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

Optimizing the Management of Retinal Vein Occlusion Through Imaging and Treatment Regimens

• Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
  Activity Chair: Rishi P. Singh, MD
  Faculty: Yasha Modi, MD; Nathan C. Steinle, MD

Welcome and Announcements

Non-Exudative CNVM: What to Look for and How to Manage Them?

• Caroline R. Baumal, MD, FASRS

Q&A

Pegcetacoplan DERBY and OAKS Phase 3 Study Results

• Caroline R. Baumal, MD, FASRS

Q&A

Biosimilars in Retinal Disease

• Robert L. Avery, MD

Q&A

CATT in 2022: Are the Results Still Relevant?

• Glenn J. Jaffe, MD

Q&A

OCT Risk Factors for Late AMD: Implications for Clinical Practice

• SriniVas Sadda, MD

Q&A

Refreshments and Networking in the Exhibit Hall

Faricimab for nAMD Phase 3 TENAYA and LUCERNE Studies

• Rishi P. Singh, MD

Q&A

Update on the Port Delivery System for nAMD

• Carl D. Regillo, MD

Q&A

Gene Therapy for Exudative AMD

• Lejla Vajzovic, MD

Q&A

Aqueous Chlorhexidine Compared with Povidone-iodine as Ocular Antisepsis before Intravitreal Injection: A Randomized Clinical Trial

• Sunir J. Garg, MD, FACS

Q&A

Refreshments and Networking in the Exhibit Hall

Panel Discussion

• Moderator: Carl D. Regillo, MD
  Panelists: Robert L. Avery, MD; Sunir J. Garg, MD, FACS; Glenn J. Jaffe, MD; SriniVas Sadda, MD; Basil K. Williams Jr, MD

Diabetic Macular Edema: Inflammatory Markers and Their Role as Potential Therapeutic Targets

• Supported by an educational grant from AbbVie Inc.
  Activity Chair: Peter K. Kaiser, MD
  Faculty: Michael S. Ip, MD; Judy E. Kim, MD, FARVO, FASRS

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

NMOSD Management: Rise of the Biologics

• Supported by an educational grant from Genentech, a member of the Roche Group
  Activity Chair: Prem S. Subramanian, MD, PhD
  Faculty: Andrew G. Lee, MD

Case Challenges: Early Interventions and Treatment Protocols in Patients With Diabetic Retinopathy

• Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
  Activity Chair: Jorge A. Fortun, MD
  Faculty: Peter K. Kaiser, MD; Yasha Modi, MD

Welcome and Announcements

Diabetic Tractional Detachments: Surgical Management Tips

• Rishi P. Singh, MD

Q&A

Diabetic Retinopathy Screening: A Different Approach

• Yasha S. Modi, MD

Q&A

Update on Brolucizumab for DME

• Michael S. Ip, MD

Q&A

Update on Faricumab for DME

• Caroline R. Baumal, MD, FASRS

Q&A

Update from the DRCR Retina Network

• Judy E. Kim, MD

Q&A

OCTA Imaging of Diabetic Retinopathy

• Anita Barikian, MD, FASRS, FAAO

Q&A

Refreshments and Networking in the Exhibit Hall

Treatment for Central Retinal Vein Occlusion: Does Fluid Status Matter?

• Michael S. Ip, MD

Q&A

Management of Vitreous Hemorrhage from Proliferative Diabetic Retinopathy

• Katherine E. Talcott, MD

Q&A

Gene Therapy for Diabetic Retinopathy Severity

• Michael S. Ip, MD

Q&A

Lost to Follow-up and Diabetic Retinopathy

• Katherine E. Talcott, MD

Q&A

Refreshments and Networking in the Exhibit Hall

Retinal Vascular Disease Panel Discussion

• Moderator: Michael S. Ip, MD
  Panelists: Robert L. Avery, MD; Yasha S. Modi, MD; Judy E. Kim, MD; Katherine E. Talcott, MD

Tie2 Activation as an Approach to Retinal Disease Treatment: New Perspectives

• Supported by an educational grant from Genentech, a member of the Roche Group.
  Activity Chair: Judy E. Kim, MD, FARVO, FASRS
  Faculty: Rishi P. Singh, MD

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

A Case Series: Identifying Opportunities for Integration

• This promotional educational event is presented by Allergan, an AbbVie company.
  Moderator: Caroline R. Baumal, MD
  Faculty: Michael S. Ip, MD; Yasha S. Modi, MD; Sunil K. Srivastava, MD
  **This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2022 or its accredited provider.

Welcome and Announcements

Surgical Management of Pediatric Retinal Detachment

• Caroline R. Baumal, MD, FASRS

Q&A

Pediatric Epiretinal Membranes: Differential Diagnosis and Management

• Lejla Vajzovic, MD

Q&A

Management of Pediatric and Adult-onset Coats Disease

• Caroline R. Baumal, MD, FASRS

Q&A

What Do We Expect to See after Radiation for Choroidal Melanoma

• Basil K. Williams Jr, MD

Q&A

Retinal Side Effects after Chemotherapy

• William F. Mieler, MD

Q&A

Indications and Approach to Biopsy of Intraocular Tumors

• Basil K. Williams Jr, MD

Q&A

Refreshments and Networking in the Exhibit Hall

Do Not Miss These Diagnoses!

• Steven Yeh, MD

Q&A

Imaging Pearls for Uveitis

• Yasha S. Modi, MD

Q&A

My Best Uveitis Cases

• Glenn J. Jaffe, MD

Q&A

Learn from My Mistakes in Uveitis Cases

• Sunil K. Srivastava, MD

Q&A

Refreshments and Networking in the Exhibit Hall

Inherited Retinal Disease Fascinomas

• William F. Mieler, MD

Q&A

Practical Considerations for Subretinal Gene Therapy Delivery

• Lejla Vajzovic, MD

Q&A

What’s the Right Dose of Anti-VEGF for Pediatric Patients?

• Robert L. Avery, MD

Q&A

Update on Gene Therapy for Inherited Retinal Disease

• Lejla Vajzovic, MD

Q&A

Geographic Atrophy: Emerging Treatment Options That Focus on the Complement Cascade

• Supported by an educational grant from Apellis.
  Activity Chair: Nathan C. Steinle, MD
  Faculty: Caroline Baumal, MD; Lejla Vajzovic, MD, FASRS

Announcement Coming Soon!

• *This session is not approved for AMA PRA Category 1 Credit(s)™.

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

Join your colleagues on a journey through the legends and history of Hawaii complete with stories, drumbeats, folk music, hula dancing and fire performers. This event is open to all attendees and their guests; an additional fee is required – please register directly with the resort (select Thursday, January 20, 2022 to be with our group).

• *This session is not approved for AMA PRA Category 1 Credit(s)™.

X-Linked Retinitis Pigmentosa and Gene Therapy: More Than Meets the Eye

• Supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Global Services, LLC
  Activity Chair: Yasha Modi, MD
  Faculty: Lejla Vajzovic, MD

Welcome and Announcements

Techniques for PVR Surgery

• Carl D. Regillo, MD

Q&A

Management of Submacular Hemorrhage

• Sophie J. Bakri, MD

Q&A

Controversies in the Management of Posterior Segment Open-globe Injuries

• William F. Mieler, MD

Q&A

Vitreoretinal Surgery Techniques for Infectious and Inflammatory Retinal Diseases

• Sunil K. Srivastava, MD

Q&A

Hypersonic Vitrectomy

• Sunir J. Garg, MD, FACS

Q&A

Refreshments and Networking in the Exhibit Hall

Panel Discussion

• Moderator: Sophie J. Bakri, MD
  Panelists: Sunir J. Garg, MD, FACS; William F. Mieler, MD; Sunil K. Srivastava, MD; Lejla Vajzovic, MD; Steven Yeh, MD

Refreshments and Networking in the Exhibit Hall

Case Presentations and Panel Discussion

• Moderator: Sophie J. Bakri, MD
  Panelists: Glenn J. Jaffe, MD; William F. Mieler, MD; Sunil K. Srivastava, MD; Steven Yeh, MD

Meeting Concludes